182 related articles for article (PubMed ID: 38450938)
1. Acquired hypothalamic obesity: A clinical overview and update.
Roth CL; McCormack SE
Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():34-45. PubMed ID: 38450938
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Roth CL; Zenno A
Front Endocrinol (Lausanne); 2023; 14():1256514. PubMed ID: 37780616
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention.
Roth CL
J Clin Med; 2015 Sep; 4(9):1774-97. PubMed ID: 26371051
[TBL] [Abstract][Full Text] [Related]
4. Management of Hypothalamic Obesity.
Müller HL
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):533-552. PubMed ID: 32741487
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic Obesity: Prologue and Promise.
Abuzzahab MJ; Roth CL; Shoemaker AH
Horm Res Paediatr; 2019; 91(2):128-136. PubMed ID: 30884480
[TBL] [Abstract][Full Text] [Related]
6. Approach to the Patient With Hypothalamic Obesity.
Shoemaker AH; Tamaroff J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1236-1242. PubMed ID: 36413492
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Dimitri P
Front Endocrinol (Lausanne); 2022; 13():846880. PubMed ID: 35464063
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic obesity.
Babcock Gilbert S; Roth LW
Minerva Endocrinol; 2015 Mar; 40(1):61-70. PubMed ID: 25370939
[TBL] [Abstract][Full Text] [Related]
10. G
Chen M; Wilson EA; Cui Z; Sun H; Shrestha YB; Podyma B; Le CH; Naglieri B; Pacak K; Gavrilova O; Weinstein LS
Mol Metab; 2019 Jul; 25():142-153. PubMed ID: 31014927
[TBL] [Abstract][Full Text] [Related]
11. Monogenic human obesity syndromes.
Farooqi IS
Handb Clin Neurol; 2021; 181():301-310. PubMed ID: 34238466
[TBL] [Abstract][Full Text] [Related]
12. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic obesity in children.
Bereket A; Kiess W; Lustig RH; Muller HL; Goldstone AP; Weiss R; Yavuz Y; Hochberg Z
Obes Rev; 2012 Sep; 13(9):780-98. PubMed ID: 22577758
[TBL] [Abstract][Full Text] [Related]
14. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.
Lee M; Korner J
Pituitary; 2009; 12(2):87-95. PubMed ID: 18327643
[TBL] [Abstract][Full Text] [Related]
15. [Hypothalamic dysfunction in obesity].
van de Sande-Lee S; Velloso LA
Arq Bras Endocrinol Metabol; 2012 Aug; 56(6):341-50. PubMed ID: 22990637
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic obesity.
Hochberg I; Hochberg Z
Endocr Dev; 2010; 17():185-196. PubMed ID: 19955767
[TBL] [Abstract][Full Text] [Related]
17. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Ni W; Shi X
World Neurosurg; 2018 Oct; 118():e59-e71. PubMed ID: 29945001
[TBL] [Abstract][Full Text] [Related]
18. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity.
Irani BG; Dunn-Meynell AA; Levin BE
Endocrinology; 2007 Jan; 148(1):310-6. PubMed ID: 17023527
[TBL] [Abstract][Full Text] [Related]
19. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.
Trivin C; Busiah K; Mahlaoui N; Recasens C; Souberbielle JC; Zerah M; Sainte-Rose C; Brauner R
BMC Pediatr; 2009 Apr; 9():24. PubMed ID: 19341477
[TBL] [Abstract][Full Text] [Related]
20. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity.
Roth CL; Eslamy H; Werny D; Elfers C; Shaffer ML; Pihoker C; Ojemann J; Dobyns WB
Obesity (Silver Spring); 2015 Jun; 23(6):1226-33. PubMed ID: 25884561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
